CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights

PUBT · 1d ago
CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights
  • Bpifrance Participations crossed above 10% of voting rights on Aug. 14, 2026 due to a lower total vote count.
  • Holding totaled 3,677,453 shares, equal to 7.22% of capital, representing 5,962,713 voting rights, or 10.03%.
  • CDC held 5,963,295 shares indirectly, equal to 11.71% of capital, representing 8,248,555 voting rights, or 13.87%.
  • Bpifrance Participations does not plan to buy more shares or seek control over the next six months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exosens SA published the original content used to generate this news brief on August 20, 2026, and is solely responsible for the information contained therein.